Vital-Zymes Complete
Withdrawn from the US market on 18 February 2025 (according to the DSLD)
Klaire Labs, food supplement from the US market
Label withdrawn from the US market. Vital-Zymes Complete (Klaire Labs), a food supplement au code-barres 709616310007, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Klaire Labs
- Barcode
- 709616310007
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- number of servings per day not stated
- Other ingredients (in English, as written)
- Hydroxypropyl Methylcellulose, Water, Ascorbyl Palmitate, Microcrystalline Cellulose
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Comprehensive Enzyme Blend | Blend | 750 mg |
| Carbohydrate Specific Enzymes | Blend | not stated |
| Amylases | Enzyme | not stated |
| Alpha-Amylases | Enzyme | not stated |
| Glucoamylase | Enzyme | not stated |
| Sugar Specific Enzymes | Blend | not stated |
| Lactase | Enzyme | not stated |
| Sucrase | Enzyme | not stated |
| Maltase | Enzyme | not stated |
| Pullulanase | Enzyme | not stated |
| Vegetable/Plant Fiber Specific Enzymes | Blend | not stated |
| Cellulase | Enzyme | not stated |
| Hemicellulase/Pectinase/Phytase Complex | Blend | not stated |
| Phytase | Enzyme | not stated |
| Beta-Glucanase | Enzyme | not stated |
| Alpha-Galactosidase | Enzyme | not stated |
| Galactomannase | Enzyme | not stated |
| Protein and Peptide Specific Enzymes | Blend | not stated |
| Acid Proteases | Enzyme | not stated |
| Alkaline Proteases | Enzyme | not stated |
| Proteases/Peptidase Complex | Blend | not stated |
| Fat Specific Enzymes | Blend | not stated |
| Lipase | Enzyme | not stated |
| Other Enzymes | ||
| Lysozyme | Enzyme | not stated |
| Serratia peptidase | Enzyme | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Serratia peptidase
Read the warning, when it applies and the studies cited
SERRAPEPTASE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gastrointestinal lesions/ulcers, a kidney or liver disorder, or are having surgery (Bhagat et al. 2013; Chopra et al. 2009; Al- Khateeb and Nusair 2008; Mazzone et al. 1990).
Sources cited by Health Canada (4)
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
- Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomised trial
- Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomised trial
- Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomised trial
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or anti-inflammatory medications (Bhagat et al. 2013; Chopra et al. 2009; Al-Khateeb and Nusair 2008; Mazzone et al. 1990).
Sources cited by Health Canada (4)
- Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomised trial
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
- Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomised trial
- Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomised trial
Known adverse reactions
Stop use if rash, difficulty breathing, hypersensitivity and/or severe allergy occur (Bhagat et al. 2013; Balagi 2007).
Sources cited by Health Canada (1)
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Klaire Labs
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Vital-Zymes Complete : étiquette retirée du marché américain (Klaire Labs): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/709616310007-vital-zymes-complete-klaire-labs, updated 18 February 2025.